AspenBio Pharma Announces Public Offering of 4,482,609 Common Shares
Conatus Pharmaceuticals to Present at the Montgomery Healthcare Conference
AspenBio Pharma Announces Closing of Public Offering of 5,155,000 Common Shares
Stem Cell Therapeutics Corp. Announces Private Placement
Amarin Corporation PLC (AMRN) Announces $70 Million Private Placement
To keep up to date with news from this category use our
ART Secures up to $1.2 Million in Interim Financing in Connection with the Pursuit of its Strategic Review Process and Files a Notice of Intention Under the Bankruptcy and Insolvency Act
Montreal, Canada, November 2, 2009 - ART Advanced Research Technologies Inc. (ART) (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical...
PDL BioPharma Announces Closing of $300,000,000 Securitization Transaction
INCLINE VILLAGE, Nev., Nov. 2, 2009 -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that it closed on its previously disclosed $300 million securitization transaction intended to monetize certain of its...
Varian Medical Systems Selected to Supply Major Project to Bring Advanced Radiotherapy Treatments to North of Portugal Cancer Patients to Benefit from State-of-the-Art RapidArc and Novalis Tx Installations
PORTO, Portugal, Oct. 30, 2009-- Cancer patients in northern Portugal will gain access to advanced cancer treatments with the acquisition of seven new treatments machines from Varian Medical Systems (NYSE: VAR) by the...
CEL-SCI Corporation Strengthens Balance Sheet Through Receipt of $10 Million From Warrant Exercises
VIENNA, Va., Oct. 26 -- CEL-SCI Corporation (NYSE Amex: CVM) announced today that it has received over $10 million over the past 60 days through the exercise of warrants by investors to purchase the Company's common...
St. Jude Medical Board of Directors Authorizes Share Repurchase
ST. PAUL, Minn.----Oct. 23, 2009-- St. Jude Medical, Inc. (NYSE:STJ) announced today that its Board of Directors has authorized a share repurchase of up to $500 million of its outstanding common stock. The repurchases...
PhotoMedex Raises $2.7 Million in Private Placement of Common Stock
MONTGOMERYVILLE, Pa.----Oct. 23, 2009-- PhotoMedex, Inc. (Nasdaq:PHMD) today announced that it has closed a private placement of approximately 4.17 million shares of its common stock at a price of $0.65 per share. Gross...
COLUMBIA LABORATORIES ANNOUNCES REGISTERED DIRECT COMMON STOCK OFFERING
LIVINGSTON, NJ -- October 23, 2009 -- Columbia Laboratories, Inc. (Nasdaq: CBRX) today announced that it has priced a transaction to raise up to approximately $11,772,000 through the sale of up to approximately...
Ad hoc announcement in accordance with
Planegg-Martinsried, Germany, October 23, 2009 - 4SC AG (Frankfurt, Prime Standard: VSC) the drug discovery and development company, today announced that its Management Board, with the approval of the Supervisory Board,...
API successfully completes the institutional component of its $150m equity raising
October 23, 2009 - Australian Pharmaceutical Industries (ASX: API), a leading Australian healthcare company and one of Australia's leading health and beauty retailers, today announced the successful completion of its...
Inhibitex Announces Equity Financing of $23 Million
ATLANTA-- October 23, 2009-- Inhibitex, Inc. (Nasdaq: INHX) today announced that it has entered into definitive purchase agreements with institutional investors for the sale of approximately $23 million of its common...
PharmaGap Announces Completion of Securities Lending Arrangements with Stormont.
Ottawa, Ontario/October 21, 2009 - PharmaGap Inc. (TSX-V: GAP; OTC.BB: PHRGF) ("PharmaGap" or "the Company") today advises that the Securities Lending Agreements ("SLA") between SC Stormont Holdings Inc. ("Stormont")...
AGA Medical Holdings, Inc. Announces Pricing of its Initial Public Offering
MINNEAPOLIS, Oct. 21, 2009 -- AGA Medical Holdings, Inc. (the "Company") announced the pricing of its initial public offering of 13,750,000 shares of common stock at $14.50 per share. The Company expects to sell...
Alfacell Corporation Announces Closing of $3.25 Million Private Placement
SOMERSET, N.J., Oct. 20, 2009 -- Alfacell Corporation (Pink Sheets:ACEL) today announced that it has closed a private placement with certain investors in which it raised $3.25 million in gross proceeds through the sale...
iCo Therapeutics Announces $4,000,000 Brokered Private Placement
October 20, 2009 -- VANCOUVER, Canada-- iCo Therapeutics Inc. (TSX-V: ICO) ("iCo" or the "Company") is pleased to announce that Loewen, Ondaatje, McCutcheon Limited and Versant Partners Inc. (collectively, the "Agents")...
PAR PHARMACEUTICAL ANNOUNCES "MODIFIED DUTCH AUCTION" TENDER OFFER TO PURCHASE UP TO $65,000,000 AGGREGATE PRINCIPAL AMOUNT OF ITS CURRENTLY OUTSTANDING 2.875% SENIOR SUBORDINATED CONVERTIBLE NOTES DUE 2010
Woodcliff Lake, New Jersey, October 14, 2009 - Par Pharmaceutical Companies, Inc. (NYSE:PRX), today announced that it has commenced a "Modified Dutch Auction" tender offer for a portion of its outstanding 2.875% Senior...
AspenBio Pharma Announces Closing of Public Offering of 5,155,000 Common Shares
CASTLE ROCK, CO -- 10/14/2009 -- AspenBio Pharma, Inc. (NASDAQ: APPY) today announced the closing of its previously announced public offering of 5,155,000 shares of its common stock at $1.70 per share. The aggregate...
Amarin Corporation PLC (AMRN) Announces $70 Million Private Placement
DUBLIN--October 13, 2009--Amarin Corporation plc today announced it has entered into a definitive agreement with several existing and new institutional and accredited investors for a $70 million private placement.
Allos Therapeutics Announces Closing of Public Offering
WESTMINSTER, Colo.--Oct. 13, 2009-- Allos Therapeutics, Inc. (Nasdaq: ALTH) today announced the closing of its previously announced underwritten public offering of 14,000,000 shares of newly issued common stock at a...
AspenBio Pharma Announces Public Offering of 4,482,609 Common Shares
CASTLE ROCK, CO -- 10/07/2009 -- AspenBio Pharma, Inc. (NASDAQ: APPY) today announced that it has priced a public offering of 4,482,609 shares of its common stock at $1.70 per share. The approximately $7.2 million of...
MedaSorb Technologies Corporation Raises $1.3M in Series B Warrant Exercise
MONMOUTH JUNCTION, NJ-- 10/09/09 - MedaSorb Technologies Corporation (OTC.BB:MSBT - News) and its wholly-owned subsidiary CytoSorbents, Inc., announced that it has raised $1.3 million in the exercise of the warrant...
Solutia Announces Pricing of $400 Million of Senior Unsecured Notes
ST. LOUIS, Oct. 9, 2009 -- Solutia Inc. (NYSE: SOA) today announced that it has priced a public offering of $400 million aggregate principal amount of senior unsecured notes due 2017, $100 million more than previously...
ADVENTRX Pharmaceuticals Announces Closing of Financing
SAN DIEGO, Oct. 9 -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) announced today that it has completed the previously announced sale of shares of its Series D convertible preferred stock pursuant to a registered...
Thermo Fisher Scientific Provides Notice of Conversion Right to Debenture Holders
WALTHAM, Mass.---Oct. 9, 2009-- As required under the indenture covering Apogent Technologies Inc. Floating Rate Convertible Senior Debentures due 2033 (CUSIP No. 03760AAK7), Thermo Fisher Scientific Inc. (NYSE: TMO) is...
Stereotaxis Announces Pricing of $26 Million Common Stock Offering
ST. LOUIS, October 09, 2009-- Stereotaxis, Inc. (Nasdaq: STXS) announced today that it had priced the public offering of 6,500,000 shares of its common at a price to the public of $4.00 per share. Stereotaxis has...
United BioSource Corporation Receives $125 Million Growth Equity Investment
October 08, 2009--United BioSource Corporation today announced that Berkshire Partners LLC, a Boston-based private equity firm, has made a $125 million growth equity investment to support the Company's evidence-based...
Lexicon Announces Pricing of Common Stock in Public Offering
The Woodlands, Texas, October 8, 2009 - Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the pricing of a public offering of 33,333,333 shares of its common stock at $1.50 per share, of which 19,894,076...
Targacept Announces Common Stock Offering
October 08, 2009--Targacept, Inc. (NASDAQ: TRGT) announced today the pricing of an underwritten public offering of 2,200,000 shares of its common stock. Deutsche Bank Securities will act as sole manager for the...
Targacept Announces Pricing of Common Stock Offering
October 08, 2009--Targacept, Inc. (NASDAQ: TRGT) announced today that the recently announced underwritten public offering of 2,200,000 shares of its common stock has been priced at a price to the public of $21.00 per...
Stereotaxis Announces Public Offering of Common Stock
ST. LOUIS, Oct. 8, 2009 -- Stereotaxis, Inc. (Nasdaq: STXS) announced today that it intends, subject to market and other conditions, to offer up to $25 million of its common stock in a registered public offering...
Grant of Warrants and Share Options to Directors
October 08, 2009--The Company, as part of the announcement made on 25 June 2009, notified its intention to award certain share options and warrants to the board.
Stem Cell Therapeutics Corp. Announces Private Placement
CALGARY, ALBERTA-- Oct. 8, 2009--Stem Cell Therapeutics Corp. ("SCT" or the "Corporation") (TSX VENTURE:SSS) is pleased to announce that it has entered into an agreement with J.F. Mackie & Company Ltd. (the "Agent")...
GRANT OF WARRANTS TO EMPLOYEES IN GENMAB A/S
Copenhagen, Denmark; October 8, 2009 - Genmab A/S (OMX: GEN) announced today that on a board meeting on October 8, 2009 the board decided to issue 200,750 warrants to employees of the company as well as the company's...
Sernova Corp. Announces Private Placement - Company To Present At Biocontact Conference In Quebec City
London, Ontario - October 7th, 2009 - Sernova Corp. (TSX-V: SVA) today announced that it is undertaking a non-brokered private placement offering of up to 6.6 million Units at a price of $0.15 per Unit for gross...
Mimetogen Pharmaceuticals Completes Key Equity Financing for Ophthalmology Drugs
Montr
Talecris Announces Closing of Initial Public Offering and Exercise of Over - Allotment Option
Research Triangle Park, N.C. (October 7, 2009) -- Talecris Biotherapeutics Holdings Corp. (NASDAQ:TLCR) ("Talecris" or the "Company") today announced the closing on October 6 of its initial public offering of shares of...
MedMira's Partnership Strategy Results in $2 Million Equity Investment from Switzerland
Halifax, Nova Scotia, October 7, 2009 - MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology and solutions, announced today that the Company will receive...
Allos Therapeutics Announces Pricing of Public Offering of Common Stock
WESTMINSTER, Colo.--Oct. 7, 2009-- Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced the pricing of an underwritten public offering of 14,000,000 primary shares of its common stock at a public offering price of...
Lexicon Announces Proposed Offering of 27,500,000 Shares of Common Stock
The Woodlands, Texas, October 7, 2009 - Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it is offering to sell, subject to market and other conditions, 27,500,000 shares of its common stock pursuant to...
Inviragen, Inc. subscribes to R&D Time software and services
6 October 2009 -- Inviragen and SingVax have merged their complementary vaccine pipelines and their international product development capabilities to create a company that is developing a wide range of vaccines for...
Pluristem Therapeutics to Raise $3.0 Million in Registered Direct Offering
HAIFA, Israel--October 06, 2009--Pluristem Therapeutics Inc.. (NasdaqCM:PSTI) (DAX:PJT) today announced that it has entered into definitive agreements with selected institutional investors to sell common stock and...
Inviragen Merges with SingVax and Completes US$15 million Financing
October 06, 2009--Inviragen and SingVax have merged their complementary vaccine pipelines and their international product development capabilities to create a company that is developing a wide range of vaccines for...
mtm laboratories Extends Series C Financing Round by EUR 7 Million Bringing Total to EUR 39 Million (USD 57 Million)
Heidelberg, Germany; October 5, 2009- mtm laboratories, a privately held diagnostics company developing, manufacturing and globally commercializing in vitro diagnostics for cervical cancer early detection and diagnosis,...
Sinclair Pharma Plc Re - Convertible Unsecured Loan Note
5 October 2009, Godalming, UK: Sinclair Pharma plc (the "Company" or "Sinclair": SPH:L), the international specialty pharma company, today announces that further to the announcement on 23 September regarding the...
Dyax Announces Completion of Common Stock Offering
CAMBRIDGE, Mass.--Oct. 5, 2009-- Dyax Corp. (NASDAQ: DYAX) today announced the completion of the public offering of 5,500,000 shares of its common stock. The net proceeds to Dyax from the sale of shares in this...
Rockwell Medical Announces Closing of $22 Million Registered Direct Offering of Shares and Warrants
WIXOM, Mich. - October 5, 2009--Rockwell Medical Technologies, Inc. (Nasdaq: RMTI) a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ERSD), chronic...
Solutia Announces Offering of Senior Notes
ST. LOUIS, Oct. 5, 2009 -- Solutia Inc. (NYSE: SOA) today announced that it will commence a public offering of $300 million aggregate principal amount of senior notes due 2017 to be guaranteed by certain of its domestic...
Allos Therapeutics Announces Proposed Public Offering of Common Stock
WESTMINSTER, Colo.--Oct. 5, 2009-- Allos Therapeutics, Inc. (Nasdaq: ALTH) today announced that it is offering to sell, subject to market and other conditions, 11,000,000 primary shares of its common stock pursuant to...
Conatus Pharmaceuticals to Present at the Montgomery Healthcare Conference
SAN DIEGO, October 5, 2009 -- Conatus Pharmaceuticals Inc., a privately held, clinical stage company developing a treatment for liver disease associated with Hepatitis C Virus (HCV), announced today that Steven J....
LANNETT COMPANY FILES UNIVERSAL SHELF REGISTRATION STATEMENT ON FORM S-3
Philadelphia, PA - October 2, 2009 - Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that it has filed a $150 million universal shelf registration statement on Form S-3...
Alexza to Raise $19.7 Million in Private Placement
MOUNTAIN VIEW, Calif., Sept. 30 -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it has entered into a definitive agreement with various institutional investors to raise $19.7 million in a private...
Celsion Corporation Announces $7.1 Million Registered Direct Offering
COLUMBIA, Md., Sep 28, 2009 -- Celsion Corporation (the "Company") (NASDAQ: CLSN), an innovative oncology drug development company dedicated to the development and commercialization of innovative oncology drugs, today...
Convertible Notes (VHLG) Proposed Noteholder Meeting - November 2009
September 25, 2009-- Virax Holdings Limited (ASX:VHL) announces that the Board has resolved to support a proposal to amend the terms of the Company's Convertible Notes. The proposal will be considered by Noteholders at...
BSD Medical Corporation Files $50 Million Shelf Registration
SALT LAKE CITY, September 24, 2009--BSD Medical Corporation (NASDAQ:BSDM, www.BSDMedical.com) today announced the filing of a shelf registration statement on Form S-3 with the Securities and Exchange Commission.
Foundation of Savira Pharmaceuticals
Vienna, 23.9.2009 - Savira, an Austrian pharmaceutical company focusing on the development of novel anti-influenza drugs was recently established in Vienna and supported with seed financing of 1 Mio Euro by the AWS...
iBio Completes $3 Million Private Placement
NEWARK, DE - September 10, 2009 - iBio, Inc. (OTCBB: IBPM) today announced a private placement of approximately $3 million of its common stock principally to current stockholders who previously purchased the Company's...
ZIOPHARM Announces At Market Private Placement of $5.05 Million
NEW YORK, Sep 09, 2009 -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today that it has entered into definitive agreements with both existing and new investors to raise approximately $5.05 million in gross...
Clavis Pharma announces Successful Completion of Share Offering
Oslo, Norway, 18 August 2009--Clavis Pharma ASA (OSE:CLAVIS) today announced the successful completion of the subsequent share offering, following the private placement in June that raised NOK 129 million in gross...
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
